1Neurology® PodcastThe Neurology® podcast is introduced by Editor-in-Chief Robert A. Gross, MD, PhD, who discusses several highlighted articles in the current issue of the journal. The podcast features an interview with the author of an article in the current issue that summarizes the paper and discusses the main findings and clinical implications for neurologists. It concludes with the Lesson of the Week, a short segment on a topic such as a laboratory technique, statistical methods, or historical neurology. Podcast listeners can earn 0.5 AMA PRA Category 1 CME Credits by answering the multiple-choice questions in the online Podcast Quiz. The exams are posted weekly on Wednesday.

]]>http://www.aan.com/rss/?event=feed&channel=1en-uspbaskin@neurology.orgkwiersma@aan.comThu, 11 Aug 2011 15:22:12 GMTWed, 22 May 2013 04:00:02 GMTAXON RSS Extensionhttp://blogs.law.harvard.edu/tech/rss012320212223ThursdayFridaySaturdaySundayneurologypodcast@aan.comChannel Feedback263492582Neurology® Podcasthttp://www.aan.com/rss/?event=feed&channel=1http://www.aan.com/rss/images/channels/channel_1_s.jpg144144The Neurology® podcast is introduced by Editor-in-Chief Robert A. Gross, MD, PhD, who discusses several highlighted articles in the current issue of the journal. The podcast features an interview with the author of an article in the current issue that summarizes the paper and discusses the main findings and clinical implications for neurologists. It concludes with the Lesson of the Week, a short segment on a topic such as a laboratory technique, statistical methods, or historical neurology. Podcast listeners can earn 0.5 AMA PRA Category 1 CME Credits by answering the multiple-choice questions in the online Podcast Quiz. The exams are posted weekly on Wednesday.Science & MedicinetrueAmerican Academy of Neurologycleanjournal,neurology,podcastManaging Editorpbaskin@neurology.orgWeekly podcast of content from Neurology®, the official journal of the American Academy of Neurology.The Neurology® podcast is introduced by Editor-in-Chief Robert A. Gross, MD, PhD, who discusses several highlighted articles in the current issue of the journal. The podcast features an interview with the author of an article in the current issue that summarizes the paper and discusses the main findings and clinical implications for neurologists. It concludes with the Lesson of the Week, a short segment on a topic such as a laboratory technique, statistical methods, or historical neurology. Podcast listeners can earn 0.5 AMA PRA Category 1 CME Credits by answering the multiple-choice questions in the online Podcast Quiz. The exams are posted weekly on Wednesday.25351Delayed Recall - Mar 2013 - Encephalopathy of Systemic Disease Ihttp://www.aan.com/rss/index.cfm/getfile/AAN_2535.mp3Encephalopathies caused by endocrine, electrolyte and organ dysfunction

]]>http://www.aan.com/rss/index.cfm/getfile/AAN_2535.mp3tmb8r@virginia.eduFri, 01 Mar 2013 09:00:00 GMTAmerican Academy of Neurology2791cleanjournal,neurology,podcastEncephalopathies caused by endocrine, electrolyte and organ dysfunctionEncephalopathies caused by endocrine, electrolyte and organ dysfunction25551March 5 2013 Issuehttp://www.aan.com/rss/index.cfm/getfile/AAN_2555.mp31) Intravenous thrombolysis and 2) Topic of the month: Cerebellar ataxias. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Brett Kissela interviews Dr. Henrik Gensicke about his paper on stroke patients treated with intravenous thrombolysis. Dr. Stacey Clardy is reading our e-Pearl of the week about brachial plexopathy. In the next part of the podcast Dr. Ted Burns interviews Drs. Susan Perlman and Jeremy Schmahmann about the topic of immune-mediated cerebellar ataxias. The participants had nothing to disclose except Drs Kissela, Gensicke, Clardy, Burns, Perlman and Schmahmann.

Dr. Kissela serves on scientific advisory board for Allergan, Inc.; has received funding for travel and speaker honoraria from Allergan, Inc.; has received research support from the NIH, will receive compensation from Reata Pharmaceuticals, Inc. for serving on the Event Adjudication Committee for the BEACON study, which they are sponsoring. and provides medico-legal reviews.

Dr. Gensicke receives research support from the Swiss National Science Foundation.

Dr. Clardy served on the editorial team for the Neurology® Resident and Fellow Section.

Dr. Burns serves as Podcast Editor for Neurology®; and has received research support for consulting activities with CSL Behring and Alexion Pharmaceuticals.

Dr. Perlman serves on Medical Research Advisory Board for the National Ataxia Foundation, receives research support from Santhera Pharmaceuticals, Edison Pharmaceuticals, Friedreich Ataxia Research Alliance, and ARRAS funding via the RDN-CRC.

Dr. Schmahmann serves as an editorial board member for The Cerebellum; receives royalties from the publication of the books The cerebellum and cognition, MRI atlas of the human cerrellum and Fiber pathways of the brain; holds stock options in Brother and for legal counsel to Johnson & Johnson; receives research support from Birmingham Foundation MINDlink Foundation Sidney R. Baer Jr., Foundations and the NIH and has a patent pending for transcranial magnetic stimulation.

]]>http://www.aan.com/rss/index.cfm/getfile/AAN_2555.mp3tmb8r@virginia.eduMon, 04 Mar 2013 23:00:00 GMTAmerican Academy of Neurology1700cleanjournal,neurology,podcastLong-term outcome in stroke patients treated with intravenous thrombolysis1) Intravenous thrombolysis and 2) Topic of the month: Cerebellar ataxias. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Brett Kissela interviews Dr. Henrik Gensicke about his paper on stroke patients treated with intravenous thrombolysis. Dr. Stacey Clardy is reading our e-Pearl of the week about brachial plexopathy. In the next part of the podcast Dr. Ted Burns interviews Drs. Susan Perlman and Jeremy Schmahmann about the topic of immune-mediated cerebellar ataxias. The participants had nothing to disclose except Drs Kissela, Gensicke, Clardy, Burns, Perlman and Schmahmann. Dr. Kissela serves on scientific advisory board for Allergan, Inc.; has received funding for travel and speaker honoraria from Allergan, Inc.; has received research support from the NIH, will receive compensation from Reata Pharmaceuticals, Inc. for serving on the Event Adjudication Committee for the BEACON study, which they are sponsoring. and provides medico-legal reviews. Dr. Gensicke receives research support from the Swiss National Science Foundation. Dr. Clardy served on the editorial team for the Neurology® Resident and Fellow Section. Dr. Burns serves as Podcast Editor for Neurology®; and has received research support for consulting activities with CSL Behring and Alexion Pharmaceuticals. Dr. Perlman serves on Medical Research Advisory Board for the National Ataxia Foundation, receives research support from Santhera Pharmaceuticals, Edison Pharmaceuticals, Friedreich Ataxia Research Alliance, and ARRAS funding via the RDN-CRC. Dr. Schmahmann serves as an editorial board member for The Cerebellum; receives royalties from the publication of the books The cerebellum and cognition, MRI atlas of the human cerrellum and Fiber pathways of the brain; holds stock options in Brother and for legal counsel to Johnson & Johnson; receives research support from Birmingham Foundation MINDlink Foundation Sidney R. Baer Jr., Foundations and the NIH and has a patent pending for transcranial magnetic stimulation.25571March 12 2013 Issuehttp://www.aan.com/rss/index.cfm/getfile/AAN_2557.mp31) Pitfalls in electronic health records and 2) Topic of the month: Cerebellar ataxias. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Mike Brogan interviews Dr. Jim Bernat about his paper on pitfalls in electronic health records. Dr. Stacey Clardy is reading our e-Pearl of the week about Aicardi-Goutieres syndrome. In the next part of the podcast Dr. Ted Burns interviews Drs. Susan Perlman and Jeremy Schmahmann about the topic of other acquired cerebellar ataxias. The participants had nothing to disclose except Drs Bernat, Clardy, Burns, Perlman and Schmahmann.

Dr. Bernat serves as an editorial board member of Neurocritical Care, Neurology Today and Multiple Sclerosis and Related Diseases, receives compensation for serving on the editorial board of The Physician's Index for Ethics and Medicine and receives royalties from the publication of the book Ethical issues in Neurology.

Dr. Clardy served on the editorial team for the Neurology® Resident and Fellow Section.

Dr. Burns serves as Podcast Editor for Neurology®; and has received research support for consulting activities with CSL Behring and Alexion Pharmaceuticals.

Dr. Perlman serves on Medical Research Advisory Board for the National Ataxia Foundation, receives research support from Santhera Pharmaceuticals, Edison Pharmaceuticals, Friedreich Ataxia Research Alliance, and ARRAS funding via the RDN-CRC.

Dr. Schmahmann serves as an editorial board member for The Cerebellum; receives royalties from the publication of the books The cerebellum and cognition, MRI atlas of the human cerrellum and Fiber pathways of the brain; holds stock options in Brother and for legal counsel to Johnson & Johnson; receives research support from Birmingham Foundation MINDlink Foundation Sidney R. Baer Jr., Foundations and the NIH and has a patent pending for transcranial magnetic stimulation.

]]>http://www.aan.com/rss/index.cfm/getfile/AAN_2557.mp3tmb8r@virginia.eduMon, 11 Mar 2013 22:00:00 GMTAmerican Academy of Neurology1987cleanjournal,neurology,podcastEthical and quality pitfalls in electronic health records1) Pitfalls in electronic health records and 2) Topic of the month: Cerebellar ataxias. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Mike Brogan interviews Dr. Jim Bernat about his paper on pitfalls in electronic health records. Dr. Stacey Clardy is reading our e-Pearl of the week about Aicardi-Goutieres syndrome. In the next part of the podcast Dr. Ted Burns interviews Drs. Susan Perlman and Jeremy Schmahmann about the topic of other acquired cerebellar ataxias. The participants had nothing to disclose except Drs Bernat, Clardy, Burns, Perlman and Schmahmann. Dr. Bernat serves as an editorial board member of Neurocritical Care, Neurology Today and Multiple Sclerosis and Related Diseases, receives compensation for serving on the editorial board of The Physician's Index for Ethics and Medicine and receives royalties from the publication of the book Ethical issues in Neurology. Dr. Clardy served on the editorial team for the Neurology® Resident and Fellow Section. Dr. Burns serves as Podcast Editor for Neurology®; and has received research support for consulting activities with CSL Behring and Alexion Pharmaceuticals. Dr. Perlman serves on Medical Research Advisory Board for the National Ataxia Foundation, receives research support from Santhera Pharmaceuticals, Edison Pharmaceuticals, Friedreich Ataxia Research Alliance, and ARRAS funding via the RDN-CRC. Dr. Schmahmann serves as an editorial board member for The Cerebellum; receives royalties from the publication of the books The cerebellum and cognition, MRI atlas of the human cerrellum and Fiber pathways of the brain; holds stock options in Brother and for legal counsel to Johnson & Johnson; receives research support from Birmingham Foundation MINDlink Foundation Sidney R. Baer Jr., Foundations and the NIH and has a patent pending for transcranial magnetic stimulation. 25581March 19 2013 Issuehttp://www.aan.com/rss/index.cfm/getfile/AAN_2558.mp31) Niemann-Pick type C and 2) Topic of the month: Cerebellar ataxias. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Ted Burns interviews Dr. Matthis Synofzik about his paper on Niemann-Pick type C. Dr. Stacey Clardy is reading our e-Pearl of the week about cephalic tetanus. In the next part of the podcast Dr. Ted Burns interviews Drs. Susan Perlman and Jeremy Schmahmann about the topic of inherited ataxias. The participants had nothing to disclose except Drs Burns, Synofzik, Clardy, Perlman and Schmahmann.

Dr. Burns serves as Podcast Editor for Neurology®; and has received research support for consulting activities with CSL Behring and Alexion Pharmaceuticals.

Dr. Synofzik receives honoraria from Actelion Pharmaceuticals; receives travel funding from Movement Disorders Society and receives research support from the Volkswagen Foundation.

Dr. Clardy served on the editorial team for the Neurology® Resident and Fellow Section.

Dr. Perlman serves on Medical Research Advisory Board for the National Ataxia Foundation, receives research support from Santhera Pharmaceuticals, Edison Pharmaceuticals, Friedreich Ataxia Research Alliance, and ARRAS funding via the RDN-CRC.

Dr. Schmahmann serves as an editorial board member for The Cerebellum; receives royalties from the publication of the books The cerebellum and cognition, MRI atlas of the human cerrellum and Fiber pathways of the brain; holds stock options in Brother and for legal counsel to Johnson & Johnson; receives research support from Birmingham Foundation MINDlink Foundation Sidney R. Baer Jr., Foundations and the NIH and has a patent pending for transcranial magnetic stimulation.

]]>http://www.aan.com/rss/index.cfm/getfile/AAN_2558.mp3tmb8r@virginia.eduMon, 18 Mar 2013 22:00:00 GMTAmerican Academy of Neurology1718cleanjournal,neurology,podcastNiemann-Pick type C is frequent in adult ataxia with cognitive decline and vertical gaze palsy1) Niemann-Pick type C and 2) Topic of the month: Cerebellar ataxias. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Ted Burns interviews Dr. Matthis Synofzik about his paper on Niemann-Pick type C. Dr. Stacey Clardy is reading our e-Pearl of the week about cephalic tetanus. In the next part of the podcast Dr. Ted Burns interviews Drs. Susan Perlman and Jeremy Schmahmann about the topic of inherited ataxias. The participants had nothing to disclose except Drs Burns, Synofzik, Clardy, Perlman and Schmahmann. Dr. Burns serves as Podcast Editor for Neurology®; and has received research support for consulting activities with CSL Behring and Alexion Pharmaceuticals. Dr. Synofzik receives honoraria from Actelion Pharmaceuticals; receives travel funding from Movement Disorders Society and receives research support from the Volkswagen Foundation. Dr. Clardy served on the editorial team for the Neurology® Resident and Fellow Section. Dr. Perlman serves on Medical Research Advisory Board for the National Ataxia Foundation, receives research support from Santhera Pharmaceuticals, Edison Pharmaceuticals, Friedreich Ataxia Research Alliance, and ARRAS funding via the RDN-CRC. Dr. Schmahmann serves as an editorial board member for The Cerebellum; receives royalties from the publication of the books The cerebellum and cognition, MRI atlas of the human cerrellum and Fiber pathways of the brain; holds stock options in Brother and for legal counsel to Johnson & Johnson; receives research support from Birmingham Foundation MINDlink Foundation Sidney R. Baer Jr., Foundations and the NIH and has a patent pending for transcranial magnetic stimulation. 25591March 26 2013 Issuehttp://www.aan.com/rss/index.cfm/getfile/AAN_2559.mp31) Preclinical Alzheimer disease and 2) Topic of the month: Cerebellar ataxias. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Jeff Burns interviews Prof. Michael Ewers about his paper on preclinical Alzheimer disease. Dr. Stacey Clardy is reading our e-Pearl of the week about neurologic symptoms in relapsing polychondritis. In the next part of the podcast Dr. Ted Burns interviews Drs. Susan Perlman and Jeremy Schmahmann about the topic of inherited ataxias and sporadic, degenerative ataxias. In concluding, there is a brief statement where to find other up-to date patient information and current Patient Page. The participants had nothing to disclose except Drs Jeff Burns, Ewers, Clardy, Ted Burns, Perlman and Schmahmann.

Dr. Jeff Burns serves on the editorial board for Journal of Alzheimer's Disease; receives royalties for the publications of Early diagnosis and treatment of mild cognitive impairment and Dementia: An atlas of investigation and diagnosis; is a consultant for PRA International and receives research support from the NIH, Alzheimer's Drug Discovery Foundation, Elan, Janssen Pharmaceuticals Inc., Wyeth, Pfizer Inc, Novartis Pharmaceuticals Ltd, Danone, Avid Radiopharmaceuticals, Merck Serono and for clinical trials.

Dr. Ewers serves as Senior Editor of Alzheimer's & Dementia and receives compensation for traveling to conferences from the Alzheimer's Association and International College of Geriatric Psychoneuropharmacology.

Dr. Clardy served on the editorial team for the Neurology® Resident and Fellow Section.

Dr. Ted Burns serves as Podcast Editor for Neurology®; and has received research support for consulting activities with CSL Behring and Alexion Pharmaceuticals.


Dr. Perlman serves on Medical Research Advisory Board for the National Ataxia Foundation, receives research support from Santhera Pharmaceuticals, Edison Pharmaceuticals, Friedreich Ataxia Research Alliance, and ARRAS funding via the RDN-CRC.

Dr. Schmahmann serves as an editorial board member for The Cerebellum; receives royalties from the publication of the books The cerebellum and cognition, MRI atlas of the human cerrellum and Fiber pathways of the brain; holds stock options in Brother and for legal counsel to Johnson & Johnson; receives research support from Birmingham Foundation MINDlink Foundation Sidney R. Baer Jr., Foundations and the NIH and has a patent pending for transcranial magnetic stimulation.

]]>http://www.aan.com/rss/index.cfm/getfile/AAN_2559.mp3tmb8r@virginia.eduMon, 25 Mar 2013 22:00:00 GMTAmerican Academy of Neurology1963cleanjournal,neurology,podcastCognitive reserve associated with FDG-PET in preclinical Alzheimer disease1) Preclinical Alzheimer disease and 2) Topic of the month: Cerebellar ataxias. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Jeff Burns interviews Prof. Michael Ewers about his paper on preclinical Alzheimer disease. Dr. Stacey Clardy is reading our e-Pearl of the week about neurologic symptoms in relapsing polychondritis. In the next part of the podcast Dr. Ted Burns interviews Drs. Susan Perlman and Jeremy Schmahmann about the topic of inherited ataxias and sporadic, degenerative ataxias. In concluding, there is a brief statement where to find other up-to date patient information and current Patient Page. The participants had nothing to disclose except Drs Jeff Burns, Ewers, Clardy, Ted Burns, Perlman and Schmahmann. Dr. Jeff Burns serves on the editorial board for Journal of Alzheimer's Disease; receives royalties for the publications of Early diagnosis and treatment of mild cognitive impairment and Dementia: An atlas of investigation and diagnosis; is a consultant for PRA International and receives research support from the NIH, Alzheimer's Drug Discovery Foundation, Elan, Janssen Pharmaceuticals Inc., Wyeth, Pfizer Inc, Novartis Pharmaceuticals Ltd, Danone, Avid Radiopharmaceuticals, Merck Serono and for clinical trials. Dr. Ewers serves as Senior Editor of Alzheimer's & Dementia and receives compensation for traveling to conferences from the Alzheimer's Association and International College of Geriatric Psychoneuropharmacology. Dr. Clardy served on the editorial team for the Neurology® Resident and Fellow Section. Dr. Ted Burns serves as Podcast Editor for Neurology®; and has received research support for consulting activities with CSL Behring and Alexion Pharmaceuticals. Dr. Perlman serves on Medical Research Advisory Board for the National Ataxia Foundation, receives research support from Santhera Pharmaceuticals, Edison Pharmaceuticals, Friedreich Ataxia Research Alliance, and ARRAS funding via the RDN-CRC. Dr. Schmahmann serves as an editorial board member for The Cerebellum; receives royalties from the publication of the books The cerebellum and cognition, MRI atlas of the human cerrellum and Fiber pathways of the brain; holds stock options in Brother and for legal counsel to Johnson & Johnson; receives research support from Birmingham Foundation MINDlink Foundation Sidney R. Baer Jr., Foundations and the NIH and has a patent pending for transcranial magnetic stimulation. 25371Delayed Recall - Apr 2013 - Encephalopathy of Systemic Disease IIhttp://www.aan.com/rss/index.cfm/getfile/AAN_2537.mp3Encephalopathies caused by drugs, vitamins, infectious and autoimmune disorders

]]>http://www.aan.com/rss/index.cfm/getfile/AAN_2537.mp3tmb8r@virginia.eduMon, 01 Apr 2013 08:00:00 GMTAmerican Academy of Neurology1671cleanjournal,neurology,podcastEncephalopathies caused by drugs, vitamins, infectious and autoimmune disordersEncephalopathies caused by drugs, vitamins, infectious and autoimmune disorders25731April 2 2013 Issuehttp://www.aan.com/rss/index.cfm/getfile/AAN_2573.mp31) NMO spectrum and MS brain lesion and 2) Topic of the month: Stroke trials. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Mark Keegan interviews Dr. Lucy Matthews about her paper on seropositive NMO spectrum disorder and MS brain lesion distribution. Dr. Adam Numis is reading our e-Pearl of the week about intravascular B-cell lymphoma. In the next part of the podcast Dr. Brett Kissela interviews Dr. Joseph Broderick about IMS III trial. All the participants have disclosures.

Dr. Keegan serves as Chief Editor for eMedicine; is a consultant for Bionest and Novartis.

Dr. Matthews receives research support from UK Medical Research Council and is funded by the Clinical Research Training Fellow ship.

Dr. Numis serves on the editorial team for the Neurology® Resident and Fellow Section.

Dr. Kissela serves on scientific advisory board for Allergan, Inc.; has received funding for travel and speaker honoraria from Allergan, Inc.; has received research support from the NIH, will receive compensation from Reata Pharmaceuticals, Inc. for serving on the Event Adjudication Committee for the BEACON study, which they are sponsoring. and provides medico-legal reviews.

Dr. Broderick has served as a consultant for PhotoThera-DSMB for NEST III study and Genentech, Inc.; receives funding for travel to NIH study section and NIH-sponsored meetings, TST meeting and national meeting by Covidien and RISS Summit by Genentech and as part as invited Visiting Professor; has received research support from Boehringer Ingelheim, Concentric, EKOS, Genentech, Inc, Johnson & Johnson, Novo Nordisk, Schering-Plough Corp, Merck, and the NIH as part of NINDS funded clinical trials.

]]>http://www.aan.com/rss/index.cfm/getfile/AAN_2573.mp3tmb8r@virginia.eduMon, 01 Apr 2013 22:00:00 GMTAmerican Academy of Neurology1369cleanjournal,neurology,podcastDistinction of seropositive NMO spectrum disorder and MS brain lesion distribution1) NMO spectrum and MS brain lesion and 2) Topic of the month: Stroke trials. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Mark Keegan interviews Dr. Lucy Matthews about her paper on seropositive NMO spectrum disorder and MS brain lesion distribution. Dr. Adam Numis is reading our e-Pearl of the week about intravascular B-cell lymphoma. In the next part of the podcast Dr. Brett Kissela interviews Dr. Joseph Broderick about IMS III trial. All the participants have disclosures. Dr. Keegan serves as Chief Editor for eMedicine; is a consultant for Bionest and Novartis. Dr. Matthews receives research support from UK Medical Research Council and is funded by the Clinical Research Training Fellow ship. Dr. Numis serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Kissela serves on scientific advisory board for Allergan, Inc.; has received funding for travel and speaker honoraria from Allergan, Inc.; has received research support from the NIH, will receive compensation from Reata Pharmaceuticals, Inc. for serving on the Event Adjudication Committee for the BEACON study, which they are sponsoring. and provides medico-legal reviews. Dr. Broderick has served as a consultant for PhotoThera-DSMB for NEST III study and Genentech, Inc.; receives funding for travel to NIH study section and NIH-sponsored meetings, TST meeting and national meeting by Covidien and RISS Summit by Genentech and as part as invited Visiting Professor; has received research support from Boehringer Ingelheim, Concentric, EKOS, Genentech, Inc, Johnson & Johnson, Novo Nordisk, Schering-Plough Corp, Merck, and the NIH as part of NINDS funded clinical trials.25741April 9 2013 Issuehttp://www.aan.com/rss/index.cfm/getfile/AAN_2574.mp31) PML diagnostic criteria: Consensus statement from AAN Neuroinfectious Disease Section and 2) Topic of the month: Stroke trials. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Andy Southerland interviews Dr. Joseph Berger about the consensus paper from the PML Guidelines Committee of the AAN Neuroinfectious Disease Section. Dr. Andy Numis is reading our e-Pearl of the week about spinal epidural abscesses. In the next part of the podcast Dr. Brett Kissela interviews Dr. Marc Chimowitz about SAMMPRIS trial. The participants had nothing to disclose except Drs. Berger, Numis, Kissela and Chimowitz.

Dr. Berger serves as an Associate Editor for the Journal of Neurovirology, serves as an editorial board member of ISRN Education, Neuroscience, World Journal of Rheumatology and MS and other related disorders; serves on the PML adjudication committees of Millenium/Takeda and Amgen; has served as a consultant to Millennium/Takeda, Amgen, Genzyme, Eisai and Novartis; and receives honoraria from Genzyme.

Dr. Numis serves on the editorial team for the Neurology® Resident and Fellow Section.

Dr. Kissela serves on scientific advisory board for Allergan, Inc.; has received funding for travel and speaker honoraria from Allergan, Inc.; has received research support from the NIH, will receive compensation from Reata Pharmaceuticals, Inc. for serving on the Event Adjudication Committee for the BEACON study, which they are sponsoring. and provides medico-legal reviews.

Dr. Chimowitz serves as an editorial board member for the journals Stroke and Neurosurgery; has received grant support from NIH/ NINDS to lead multicenter trials on the treatment of intracranial arterial stenosis; for these NIH funded trials, he has also received research support from Stryker Corporation (donation of intracranial stents, payments for 3rd party monitoring of trial), AstraZeneca Corporation (donation of statin), Bayer (donation of aspirin and placebo) and Bristol Myers Squibb (donation of warfarin and placebo); serves on the data safety monitoring board for an industry funded PFO closure study sponsored by Gore Corporation and on a stroke event adjudication panel for an osteoporosis trial funded by Merck and has also provided medico-legal reviews on stroke related cases.

]]>http://www.aan.com/rss/index.cfm/getfile/AAN_2574.mp3tmb8r@virginia.eduMon, 08 Apr 2013 22:00:00 GMTAmerican Academy of Neurology1916cleanjournal,neurology,podcastPML diagnostic criteria: Consensus statement from the PML Guidelines Committee of the AAN Neuroinfectious Disease Section1) Consensus statement from AAN Neuroinfectious Disease Section and 2) Topic of the month: Stroke trials. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Andy Southerland interviews Dr. Joseph Berger about the consensus paper from the PML Guidelines Committee of the AAN Neuroinfectious Disease Section. Dr. Andy Numis is reading our e-Pearl of the week about spinal epidural abscesses. In the next part of the podcast Dr. Brett Kissela interviews Dr. Marc Chimowitz about SAMMPRIS trial. The participants had nothing to disclose except Drs. Berger, Numis, Kissela and Chimowitz. Dr. Berger serves as an Associate Editor for the Journal of Neurovirology, serves as an editorial board member of ISRN Education, Neuroscience, World Journal of Rheumatology and MS and other related disorders; serves on the PML adjudication committees of Millenium/Takeda and Amgen; has served as a consultant to Millennium/Takeda, Amgen, Genzyme, Eisai and Novartis; and receives honoraria from Genzyme. Dr. Numis serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Kissela serves on scientific advisory board for Allergan, Inc.; has received funding for travel and speaker honoraria from Allergan, Inc.; has received research support from the NIH, will receive compensation from Reata Pharmaceuticals, Inc. for serving on the Event Adjudication Committee for the BEACON study, which they are sponsoring. and provides medico-legal reviews. Dr. Chimowitz serves as an editorial board member for the journals Stroke and Neurosurgery; has received grant support from NIH/ NINDS to lead multicenter trials on the treatment of intracranial arterial stenosis; for these NIH funded trials, he has also received research support from Stryker Corporation (donation of intracranial stents, payments for 3rd party monitoring of trial), AstraZeneca Corporation (donation of statin), Bayer (donation of aspirin and placebo) and Bristol Myers Squibb (donation of warfarin and placebo); serves on the data safety monitoring board for an industry funded PFO closure study sponsored by Gore Corporation and on a stroke event adjudication panel for an osteoporosis trial funded by Merck and has also provided medico-legal reviews on stroke related cases. 25751April 16 2013 Issuehttp://www.aan.com/rss/index.cfm/getfile/AAN_2575.mp31) Human herpes 6 virus encephalitis and 2) Topic of the month: Stroke trials. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Joanna Jen interviews Dr. Mina Bhanushali and Sarah Kranick about their paper on human herpes 6 virus encephalitis and stem cell transplantation. Dr. Adam Numis is reading our e-Pearl of the week about ictal syncope. In the next part of the podcast Dr. Brett Kissela interviews Dr. Clay Johnston about CHANCE trial. All the participants have disclosures.

Dr. Jen serves as an Associate Editor of Frontiers in Neuro-otology and Section Editor of Experimental Brain Research and receives research support from the FDA.

Ms. Kranick is a staff member of the National Institute of Health.

Dr. Bhanushali Is an employee of the National Institute of Health.

Dr. Numis serves on the editorial team for the Neurology® Resident and Fellow Section.

Dr. Kissela serves on scientific advisory board for Allergan, Inc.; has received funding for travel and speaker honoraria from Allergan, Inc.; has received research support from the NIH, will receive compensation from Reata Pharmaceuticals, Inc. for serving on the Event Adjudication Committee for the BEACON study, which they are sponsoring. and provides medico-legal reviews.

Dr. Johnston serves as Co-Editor-in-Chief of Journal Watch Neurology; serves as Vice Editor of Annals of Neurology; is co-holder of patent on the RNA panel to identify TIA and risk stratify; Stryker Neurovascular, Boston Scientific, Kaiser-Permanente, NCRR/NCATS, CTSA, AHA/ASA, Bugher Award and the NIH and provided expert testimony in legal proceedings for GlaxoSmithKline.

]]>http://www.aan.com/rss/index.cfm/getfile/AAN_2575.mp3tmb8r@virginia.eduMon, 15 Apr 2013 22:00:00 GMTAmerican Academy of Neurology1878cleanjournal,neurology,podcastHuman herpes 6 virus encephalitis complicating allogeneic Hematopoietic stem cell transplantation1) Human herpes 6 virus encephalitis and 2) Topic of the month: Stroke trials. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Joanna Jen interviews Dr. Mina Bhanushali and Sarah Kranick about their paper on human herpes 6 virus encephalitis and stem cell transplantation. Dr. Adam Numis is reading our e-Pearl of the week about ictal syncope. In the next part of the podcast Dr. Brett Kissela interviews Dr. Clay Johnston about CHANCE trial. All the participants have disclosures. Dr. Jen serves as an Associate Editor of Frontiers in Neuro-otology and Section Editor of Experimental Brain Research and receives research support from the FDA. Ms. Kranick is a staff member of the National Institute of Health. Dr. Bhanushali Is an employee of the National Institute of Health. Dr. Numis serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Kissela serves on scientific advisory board for Allergan, Inc.; has received funding for travel and speaker honoraria from Allergan, Inc.; has received research support from the NIH, will receive compensation from Reata Pharmaceuticals, Inc. for serving on the Event Adjudication Committee for the BEACON study, which they are sponsoring. and provides medico-legal reviews. Dr. Johnston serves as Co-Editor-in-Chief of Journal Watch Neurology; serves as Vice Editor of Annals of Neurology; is co-holder of patent on the RNA panel to identify TIA and risk stratify; Stryker Neurovascular, Boston Scientific, Kaiser-Permanente, NCRR/NCATS, CTSA, AHA/ASA, Bugher Award and the NIH and provided expert testimony in legal proceedings for GlaxoSmithKline. 25901April 23 2013http://www.aan.com/rss/index.cfm/getfile/AAN_2590.mp31) Atrial fibrillation and unexplained stroke and 2) Topic of the month: Stroke trials. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Bryan Eckerle interviews Dr. Paul Cotter about his paper on incidence of atrial fibrillation and unexplained stroke. Dr. Adam Numis is reading our e-Pearl of the week about LGI-1 antibodies in limbic encephalitis. In the next part of the podcast Dr. Brett Kissela interviews Drs. Opeolu Adeoye and Art Pancioli about the CLEAR-ER trial. The participants had nothing to disclose except Drs Cotter, Numis, Kissela and Adeoye.

Dr. Cotter receives research support from the UK National Institute for Health Research, Cambridge biomedical Research Center and Clinical Research Fellowship.

Dr. Numis serves on the editorial team for the Neurology® Resident and Fellow Section.

Dr. Kissela serves on scientific advisory board for Allergan, Inc.; has received funding for travel and speaker honoraria from Allergan, Inc.; has received research support from the NIH, will receive compensation from Reata Pharmaceuticals, Inc. for serving on the Event Adjudication Committee for the BEACON study, which they are sponsoring. and provides medico-legal reviews.

Dr. Adeoye received honoraria for serving on the speakers' bureau of Genentech, Inc. and receives research support from the NIH.

]]>http://www.aan.com/rss/index.cfm/getfile/AAN_2590.mp3tmb8r@virginia.eduMon, 22 Apr 2013 22:00:00 GMTAmerican Academy of Neurology1396cleanjournal,neurology,podcastIncidence of atrial fibrillation detected by implantable loop recorders in unexplained stroke1) Atrial fibrillation and unexplained stroke and 2) Topic of the month: Stroke trials. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Bryan Eckerle interviews Dr. Paul Cotter about his paper on incidence of atrial fibrillation and unexplained stroke. Dr. Adam Numis is reading our e-Pearl of the week about LGI-1 antibodies in limbic encephalitis. In the next part of the podcast Dr. Brett Kissela interviews Drs. Opeolu Adeoye and Art Pancioli about the CLEAR-ER trial. The participants had nothing to disclose except Drs Cotter, Numis, Kissela and Adeoye. Dr. Cotter receives research support from the UK National Institute for Health Research, Cambridge biomedical Research Center and Clinical Research Fellowship. Dr. Numis serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Kissela serves on scientific advisory board for Allergan, Inc.; has received funding for travel and speaker honoraria from Allergan, Inc.; has received research support from the NIH, will receive compensation from Reata Pharmaceuticals, Inc. for serving on the Event Adjudication Committee for the BEACON study, which they are sponsoring. and provides medico-legal reviews. Dr. Adeoye received honoraria for serving on the speakers' bureau of Genentech, Inc. and receives research support from the NIH.25911April 30 2013http://www.aan.com/rss/index.cfm/getfile/AAN_2591.mp31) Exposure to stroke belt on incident stroke and 2) Topic of the month: Stroke trials. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Andy Southerland interviews Dr. Virginia Howard about her paper on exposure to the stroke belt on incident stroke in adulthood. Dr. Adam Numis is reading our e-Pearl of the week about Neuro-Behcet's disease. In the next part of the podcast Dr. Brett Kissela focuses his interview with Dr. Chelsea Kidwell about the MR Rescue trial. The participants had nothing to disclose except Drs Howard, Numis, Kissela and Kidwell.

Dr. Howard serves on DSMB for NIH-NIDA; is a consultant for NIH review committees and receives research support from the NIH.

Dr. Numis serves on the editorial team for the Neurology® Resident and Fellow Section.

Dr. Kissela serves on scientific advisory board for Allergan, Inc.; has received funding for travel and speaker honoraria from Allergan, Inc.; has received research support from the NIH, will receive compensation from Reata Pharmaceuticals, Inc. for serving on the Event Adjudication Committee for the BEACON study, which they are sponsoring. and provides medico-legal reviews.

Dr. Kidwell serves as an editorial board member of Stroke, Neurocritical Care Journal, Journal of Neuroimaging and Stroke Research and Treatment; and receives research support from Baxter and NIH.

]]>http://www.aan.com/rss/index.cfm/getfile/AAN_2591.mp3tmb8r@virginia.eduMon, 29 Apr 2013 22:00:00 GMTAmerican Academy of Neurology1311cleanjournal,neurology,podcastThe effect of duration and age at exposure to the stroke belt on incident stroke in adulthood1) Exposure to stroke belt on incident stroke and 2) Topic of the month: Stroke trials. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Andy Southerland interviews Dr. Virginia Howard about her paper on exposure to the stroke belt on incident stroke in adulthood. Dr. Adam Numis is reading our e-Pearl of the week about Neuro-Behcet's disease. In the next part of the podcast Dr. Brett Kissela focuses his interview with Dr. Chelsea Kidwell about the MR Rescue trial. The participants had nothing to disclose except Drs Howard, Numis, Kissela and Kidwell. Dr. Howard serves on DSMB for NIH-NIDA; is a consultant for NIH review committees and receives research support from the NIH. Dr. Numis serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Kissela serves on scientific advisory board for Allergan, Inc.; has received funding for travel and speaker honoraria from Allergan, Inc.; has received research support from the NIH, will receive compensation from Reata Pharmaceuticals, Inc. for serving on the Event Adjudication Committee for the BEACON study, which they are sponsoring. and provides medico-legal reviews. Dr. Kidwell serves as an editorial board member of Stroke, Neurocritical Care Journal, Journal of Neuroimaging and Stroke Research and Treatment; and receives research support from Baxter and NIH. 25691Delayed Recall - May 2013 - Cerebellar Ataxias Ihttp://www.aan.com/rss/index.cfm/getfile/AAN_2569.mp3Immune mediated, toxic & infectious ataxias

]]>http://www.aan.com/rss/index.cfm/getfile/AAN_2569.mp3tmb8r@virginia.eduWed, 01 May 2013 08:00:00 GMTAmerican Academy of Neurology2004cleanjournal,neurology,podcastAtaxiasImmune mediated, toxic & infectious ataxias25971May 7 2013 Issuehttp://www.aan.com/rss/index.cfm/getfile/AAN_2597.mp31) Diagnosis of gluten ataxia and 2) Topic of the month: Treatment of movement disorders. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Matthew Barrett interviews Dr. Marios Hadjivassiliou about his paper on the diagnosis of gluten ataxia. Dr. Roy Strowd is reading our e-Pearl of the week about tonic spasms in multiple sclerosis. In the next part of the podcast Dr. Matthew Barrett interviews Dr. Fred Wooten about early treatment of motor symptoms. The participants had nothing to disclose except Dr. Strowd.

Dr. Strowd serves on the editorial team for the Neurology® Resident and Fellow Section.

]]>http://www.aan.com/rss/index.cfm/getfile/AAN_2597.mp3tmb8r@virginia.eduMon, 06 May 2013 22:00:00 GMTAmerican Academy of Neurology1477cleanjournal,neurology,podcastTransglutaminase 6 antibodies in the diagnosis of gluten ataxia1) Diagnosis of gluten ataxia and 2) Topic of the month: Treatment of movement disorders. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Matthew Barrett interviews Dr. Marios Hadjivassiliou about his paper on the diagnosis of gluten ataxia. Dr. Roy Strowd is reading our e-Pearl of the week about tonic spasms in multiple sclerosis. In the next part of the podcast Dr. Matthew Barrett interviews Dr. Fred Wooten about early treatment of motor symptoms. The participants had nothing to disclose except Dr. Strowd. Dr. Strowd serves on the editorial team for the Neurology® Resident and Fellow Section. 25991May 14 2013 Issuehttp://www.aan.com/rss/index.cfm/getfile/AAN_2599.mp31) MRI sign of progressive supranuclear palsy and 2) Topic of the month: Treatment of movement disorders. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. John Morgan interviews Dr. Luke Massey about his paper on an MRI sign of progressive supranuclear palsy. Dr. Roy Strowd is reading our e-Pearl of the week about the hummingbird sign. In the next part of the podcast Dr. Matthew Barrett interviews Dr. Fred Wooten about late treatment of motor symptoms. The participants had nothing to disclose except Drs. Morgan, Massey and Strowd.

Dr. Morgan is a consultant for Impax Laboratories, Inc. and Veloxis Pharmaceuticals; serves on the speakers' bureaus of GlaxoSmithKline, Teva Pharmaceuticals Industries Ltd., UCB and GE Healthcare; performed CME for Oakstone Publishing, LLC; receives research support from the NIH and received compensation for review of medical records and expert witness testimony in multiple cases of litigation involving neurologic conditions.

Dr. Massey received research support from the PSP Association Europe.

Dr. Strowd serves on the editorial team for the Neurology® Resident and Fellow Section.

]]>http://www.aan.com/rss/index.cfm/getfile/AAN_2599.mp3tmb8r@virginia.eduMon, 13 May 2013 22:00:00 GMTAmerican Academy of Neurology1140cleanjournal,neurology,podcastThe midbrain: Pons ratio: A simple and specific MRI sign of progressive supranuclear palsy1) MRI sign of progressive supranuclear palsy and 2) Topic of the month: Treatment of movement disorders. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. John Morgan interviews Dr. Luke Massey about his paper on an MRI sign of progressive supranuclear palsy. Dr. Roy Strowd is reading our e-Pearl of the week about the hummingbird sign. In the next part of the podcast Dr. Matthew Barrett interviews Dr. Fred Wooten about late treatment of motor symptoms. The participants had nothing to disclose except Drs. Morgan, Massey and Strowd. Dr. Morgan is a consultant for Impax Laboratories, Inc. and Veloxis Pharmaceuticals; serves on the speakers' bureaus of GlaxoSmithKline, Teva Pharmaceuticals Industries Ltd., UCB and GE Healthcare; performed CME for Oakstone Publishing, LLC; receives research support from the NIH and received compensation for review of medical records and expert witness testimony in multiple cases of litigation involving neurologic conditions. Dr. Massey received research support from the PSP Association Europe. Dr. Strowd serves on the editorial team for the Neurology® Resident and Fellow Section. 26001May 21 2013 Issuehttp://www.aan.com/rss/index.cfm/getfile/AAN_2600.mp31) Growing burden of neurodegenerative conditions and 2) Topic of the month: Treatment of movement disorders. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Binit Shah interviews Dr. Ray Dorsey about his paper on obtaining care for the growing burden of neurodegenerative conditions. Dr. Roy Strowd is reading our e-Pearl of the week about Huntington disease and the milk maid grip. In the next part of the podcast Dr. Binit Shah interviews Dr. Michael Okun about surgical management of Parkinson disease. The participants had nothing to disclose except Drs. Dorsey and Strowd.

Dr. Dorsey serves on the scientific advisory board for Lundbeck Inc. and Huntington's Disease Society of America; serves as an editorial board member of Journal of Huntington's Disease; is a consultant for Avid Radiopharmaceuticals, Inc., Clintrex, Lundbeck, Inc., Medtronic, Inc., National Institute of Neurological Disorders and Stroke; (30% effort) clinical practice as a movement disorder neurologist; receives research support from Google, Lundbeck, Inc.; Prana Biotechnology Limited, National Institute of Neurological Disorders and Stroke, Agency for Health Care Research and Quality; Macklin Foundation, Inc, and Verizon Foundation; holds stock options in ConsultingMD and a patent application related to telemedicine.

Dr. Strowd serves on the editorial team for the Neurology® Resident and Fellow Section.

]]>http://www.aan.com/rss/index.cfm/getfile/AAN_2600.mp3tmb8r@virginia.eduMon, 20 May 2013 22:00:00 GMTAmerican Academy of Neurology1565cleanjournal,neurology,podcastThe coming crisis: Obtaining care for the growing burden of neurodegenerative conditions1) Growing burden of neurodegenerative conditions and 2) Topic of the month: Treatment of movement disorders. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Binit Shah interviews Dr. Ray Dorsey about his paper on obtaining care for the growing burden of neurodegenerative conditions. Dr. Roy Strowd is reading our e-Pearl of the week about Huntington disease and the milk maid grip. In the next part of the podcast Dr. Binit Shah interviews Dr. Michael Okun about surgical management of Parkinson disease. The participants had nothing to disclose except Drs. Dorsey and Strowd. Dr. Dorsey serves on the scientific advisory board for Lundbeck Inc. and Huntington's Disease Society of America; serves as an editorial board member of Journal of Huntington's Disease; is a consultant for Avid Radiopharmaceuticals, Inc., Clintrex, Lundbeck, Inc., Medtronic, Inc., National Institute of Neurological Disorders and Stroke; (30% effort) clinical practice as a movement disorder neurologist; receives research support from Google, Lundbeck, Inc.; Prana Biotechnology Limited, National Institute of Neurological Disorders and Stroke, Agency for Health Care Research and Quality; Macklin Foundation, Inc, and Verizon Foundation; holds stock options in ConsultingMD and a patent application related to telemedicine. Dr. Strowd serves on the editorial team for the Neurology® Resident and Fellow Section.